Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4
- PMID: 12220104
- DOI: 10.1191/0961203302lu234oa
Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune rheumatic disease that may affect every organ or system in the body. We have shown previously that the TCR alphabeta+ subpopulation of CD3+ CD4- CD8-, DN T cells is expanded in patients with SLE and that double negative T cells express increased levels of activation markers compared both with healthy people and with patients with rheumatoid arthritis, (RA) as autoimmune controls. The aim of this study was to characterize these cells in terms of their ability to produce IL4, a Th2 cytokine, both spontaneously and after mitogen stimulation. It was found that a higher percentage of TCR alphabeta+ double negative T cells from patients with SLE contained IL4 constitutively than did the same population of cells from healthy people or from those with RA. After mitogen stimulation, there was no significant difference in the amount of IL4 produced by each of the three groups. Further study of patients producing high levels of IL4 (about one third of the patients) indicated that they had a lower percentage of alphabeta+ T cells in the double negative compartment than did patients with fewer IL4 containing cells.
Similar articles
-
Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.Lupus. 2002;11(8):493-500. doi: 10.1191/0961203302lu235oa. Lupus. 2002. PMID: 12220103
-
T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.J Immunol. 1989 Jul 1;143(1):103-12. J Immunol. 1989. PMID: 2525144
-
Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.J Autoimmun. 2001 Sep;17(2):155-63. doi: 10.1006/jaut.2001.0525. J Autoimmun. 2001. PMID: 11591124
-
IL-17 in systemic lupus erythematosus.J Biomed Biotechnol. 2010;2010:943254. doi: 10.1155/2010/943254. Epub 2010 Apr 6. J Biomed Biotechnol. 2010. PMID: 20379379 Free PMC article. Review.
-
TCRαβ+CD3+CD4-CD8- (double negative) T cells in autoimmunity.Autoimmun Rev. 2018 Apr;17(4):422-430. doi: 10.1016/j.autrev.2018.02.001. Epub 2018 Feb 9. Autoimmun Rev. 2018. PMID: 29428806 Review.
Cited by
-
Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells.J Immunol. 2015 May 1;194(9):4207-14. doi: 10.4049/jimmunol.1402775. Epub 2015 Mar 30. J Immunol. 2015. PMID: 25825451 Free PMC article.
-
T cells as therapeutic targets in SLE.Nat Rev Rheumatol. 2010 Jun;6(6):317-25. doi: 10.1038/nrrheum.2010.60. Epub 2010 May 11. Nat Rev Rheumatol. 2010. PMID: 20458333 Free PMC article. Review.
-
Double-Negative T (DNT) Cells in Patients with Systemic Lupus Erythematosus.Biomedicines. 2024 Jan 12;12(1):166. doi: 10.3390/biomedicines12010166. Biomedicines. 2024. PMID: 38255272 Free PMC article. Review.
-
Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype.J Immunol. 2009 Oct 1;183(7):4675-81. doi: 10.4049/jimmunol.0901533. Epub 2009 Sep 4. J Immunol. 2009. PMID: 19734235 Free PMC article.
-
Overview of Oxidative Stress in Systemic Lupus Erythematosus.Antioxidants (Basel). 2025 Mar 1;14(3):303. doi: 10.3390/antiox14030303. Antioxidants (Basel). 2025. PMID: 40227251 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials